minal

Right Now

Cellulite Treatment Market Size To Reach $3.37 Billion By 2030

The global cellulite treatment market size is expected to reach USD 3.37 billion by 2030, registering a CAGR of 11.1% from 2023 to 2030, according to a new report by Grand View Research, Inc. Increasing obesity rate globally and improved safety & efficacy of the treatments are some of the major growth drivers for the market. The COVID-19 pandemic negatively impacted the aesthetic industry, including the market for cellulite treatments. Government regulations and lockdowns in all countries negatively affected the global economy. According to the Plastic Surgery Statistics report for 2020, around 86,350 cellulite treatment procedures were performed in the U.S. The report also showed a decline of 24% in cellulite procedures from 2019 to 2020.

The market growth is further expected to be fueled by the introduction of innovative products in the industry. For instance, in January 2021, Candela Corporation announced the availability of the FDA-approved Frax Pro system. It is the first platform that features skin resurfacing with Frax 1940 and Frax 1550 applicators. These applicators stimulate new collagen growth by targeting different skin layers.

In June 2020, Soliton, a medical device company, announced positive results for cellulite clinical trials. The trial examined 20 to 30-minute noninvasive treatment with a rapid acoustic pulse device and it was applied to study the participant’s skin without using anesthesia. The company also reported that it would be including the study results in the marketing application to the U.S. FDA.

The market is anticipated to witness significant business activities such as mergers & acquisitions and strategic collaborations during the forecast period. This can be attributed to the emphasis on market consolidation by established players to limit competitive rivalry. For instance, according to an article by Investor's Business Daily, Inc., Allergan is estimated to seek collaboration with Endo International for international marketing of Endo’s cellulite treatment. This collaboration is anticipated to complement the body contouring and aesthetic portfolio of Allergan.

Cellulite Treatment Market Report Highlights

Based on procedure type, the non-invasive treatment segment accounted for the largest revenue share of 36.7% in 2022 and is expected to grow at the fastest CAGR of 11.3% during the forecast period. The increased accessibility of this procedure and ongoing research and development activities are key factors contributing to the growing popularity of this treatment.
Based on cellulite type, the soft cellulite segment accounted for the largest revenue share of around 46.4% in 2022 and is expected to grow at the fastest CAGR of 11.2% over the forecast period
Based on end-use, the clinics and beauty centers segment held the largest revenue of 65.1% in 2022 and is expected to grow at the fastest CAGR of 11.3% over the forecast period due to the increasing occurrence of cellular formation and other aesthetic-related conditions
In 2022, North America dominated the market with a share of 35.6% due to advanced techniques and the availability of skilled professionals. On the other hand, Asia Pacific is anticipated to grow at the fastest CAGR of 12.1% over the forecast period due to lower treatment costs, rising disposable income, and an increasing prevalence of obesity
Some of the major industry players include Merz Pharma; Hologic, Inc. (Cynosure); Syneron Medical; Zimmer Aesthetics; Alma Lasers; Cymedics; and Nubway

Detail Analysis of Cellulite Treatment Market

Cellulite Treatment Market Segmentation

Grand View Research has segmented the global cellulite treatment market based on procedure type, cellulite type, end-use, and region:

Cellulite Treatment Procedure Type Outlook (Revenue, USD Million, 2018 - 2030)